Hybrid Conferencee

International Conference on Hematology and Blood Disease (ICHBD - 26)

5th - 6th October 2026 | Helsingor, Denmark

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Helsingor. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Helsingor event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Helsingor conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Helsingor, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Helsingor."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Hematologic Malignancies

This track will explore the latest research and clinical advancements in the diagnosis and treatment of hematologic malignancies. Emphasis will be placed on novel therapeutic strategies and their implications for patient outcomes.

Track 02

Innovations in Hemato-immunology

This session will focus on the intersection of hematology and immunology, highlighting cutting-edge research in immune responses related to blood disorders. Discussions will include the role of immune therapies in managing hematologic diseases.

Track 03

Thrombosis and Hemostasis: Mechanisms and Management

This track will delve into the pathophysiology of thrombosis and hemostasis, as well as current management strategies. Participants will examine recent findings that inform clinical practice and improve patient care.

Track 04

Stem Cell Research and Its Impact on Hematology

This session will cover the latest advancements in stem cell research and their applications in treating blood disorders. Topics will include stem cell transplantation and regenerative medicine approaches.

Track 05

Diagnosis and Management of Blood Disorders

This track will address contemporary diagnostic techniques and management strategies for various blood disorders. Emphasis will be placed on integrating new technologies into clinical practice.

Track 06

Blood Disorders and Oncology: A Comprehensive Overview

This session will provide an overview of the relationship between blood disorders and oncology, focusing on the challenges and advancements in treating co-existing conditions. Discussions will include case studies and emerging therapies.

Track 07

New Drug Development in Hematology

This track will highlight the latest innovations in drug development specifically targeting hematologic conditions. Participants will discuss the drug discovery process, clinical trials, and regulatory challenges.

Track 08

Transfusion Medicine: Current Practices and Future Directions

This session will explore the evolving field of transfusion medicine, including best practices and innovations in blood product management. Topics will cover safety, efficacy, and ethical considerations in transfusion.

Track 09

Technological Advances in Hematology Research

This track will examine the impact of advanced technologies on hematology research, including genomics, proteomics, and bioinformatics. Participants will discuss how these technologies are shaping the future of blood-based products.

Track 10

Lymphatic System and Associated Hematological Diseases

This session will focus on the lymphatic system's role in hematology, exploring diseases associated with lymphatic dysfunction. Discussions will include diagnostic challenges and therapeutic approaches.

Track 11

Multidisciplinary Approaches in Hematology

This track will emphasize the importance of multidisciplinary collaboration in the management of hematological disorders. Participants will share insights on integrating various specialties to enhance patient care and outcomes.